August 2, 2021
2 mins read

India, UK to conduct clinical trials of Ashwagandha

Ashwagandha (Withania Somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger…reports Asian Lite News.

The Ayush ministry’s All India Institute of Ayurveda in collaboration with the United Kingdom’s London School of Hygiene and Tropical Medicine will conduct a study on ‘Ashwagandha’ for promoting recovery from Covid-19 in a boost to the traditional Indian medicine system.

Both the institutions signed a Memorandum of Understanding to conduct the clinical trials of Ashwagandha on 2,000 people in three UK cities — Leicester, Birmingham, and London (Southall and Wembley), said the ministry in a statement.

Ashwagandha (Withania Somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger.

It is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile. The positive effects of Ashwagandha have been observed in Covid, which is a multi-system disease with no evidence of its effective treatment or management.

The successful completion of the trial can be a major breakthrough and give scientific validity to India’s traditional medicinal system. While there have been several studies on Ashwagandha to understand its benefits in various ailments, this is the first time the Ministry has collaborated with a foreign institution to investigate its efficacy on Covid-19 patients.

AIIA director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project along with Dr Rajgopalan, Coordinator – International Projects, said that the participants have been randomly selected. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.

The participants will have to take the 500mg tablets twice a day. A monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events will be carried out.

“For three months, one group of 1,000 participants will be administered Ashwagandha (AG) tablets while the second group of 1,000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste. Both patients and the doctors will be unaware of the group’s treatment in a double-blind trial,” Dr Nesari said.

ALSO READ-World Hindu Economic Forum hosts Webinar on Ayurveda

READ MORE-Verstegen, Sri Sri Tattva join hands to offer sustainable agri solutions in Europe, UK

Previous Story

Pakistani Jihadis Join Taliban Troops in Afghanistan

Next Story

Dark days ahead for Af as Taliban imposes ‘Sharia’

Latest from -Top News

Top Indian Officials Head to Washington

The visit, likely next week, follows US President Trump’s claims that his administration helped broker the recent India-Pakistan ceasefire….reports Asian Lite News Top sources revealed on Sunday that Foreign Secretary Vikram Misri

India, Canada Discuss Enhancing Diplomatic Relations

Canada’s new Prime Minister Mark Carney is pushing for deepening economic cooperation with India….reports Asian Lite News External Affairs Minister S. Jaishankar held his first phone call with Canadian counterpart Anita Anand,

Ramaphosa gains from US showdown

South African President’s conduct with Trump reminded South Africans of his diplomatic pedigree, and of his importance to the country’s rules-based order South Africa’s President Cyril Ramaphosa and his delegation went to
Go toTop

Don't Miss

‘US Sees India As Strategic Partner and Key Global Player’

The ministers of both countries discussed the ongoing conflicts in

India’s hockey heroes Stage thrilling comeback

India, who took the lead in the ninth minute through